Modulation of NK cell activity by CpG oligodeoxynucleotides

By Ballas Zuhair  

Immunologic Research, Vol. 39, Iss. 1-3, 2007-11 ,pp. : 15-21

Humana Press, Inc

Access to resources Recommend Favorite

A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma‐affected horses, an animal model

By  

Immunity, Inflammation And Disease, Vol. 6, Iss. 1, 2018-03 ,pp. : 81-96

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment

By Shirota Hidekazu   Klinman Dennis M  

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 787-789

Future Medicine

Access to resources Recommend Favorite

CpG and Non-CpG Oligodeoxynucleotides Induce Differential Proinflammatory Gene Expression Profiles in Liver and Peripheral Blood Leukocytes in Mice

By Younis Husam   Vickers Tim   Levin Arthur   Henry Scott  

Journal of Immunotoxicology, Vol. 3, Iss. 2, 2006-07 ,pp. : 57-68

Informa Healthcare

Access to resources Recommend Favorite

CpG oligodeoxynucleotides enhance FcRI-mediated cross presentation by dendritic cells

By Bevaart Lisette  

International Immunology, Vol. 16, Iss. 8, 2004-08 ,pp. : 1091-1098

Oxford University Press

Access to resources Recommend Favorite